69 related articles for article (PubMed ID: 2308780)
41. TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.
Jin B; Scott JL; Vadas MA; Burns GF
Immunology; 1989 Apr; 66(4):570-6. PubMed ID: 2541074
[TBL] [Abstract][Full Text] [Related]
42. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
Yun YS; Hargrove ME; Ting CC
J Immunol; 1988 Aug; 141(4):1390-7. PubMed ID: 3260924
[TBL] [Abstract][Full Text] [Related]
44. Attenuation of interleukin 2-induced pulmonary vascular leak syndrome by low doses of oral methotrexate.
DeJoy SQ; Jeyaseelan R; Torley LW; Schow SR; Wick MM; Kerwar SS
Cancer Res; 1995 Nov; 55(21):4929-35. PubMed ID: 7585532
[TBL] [Abstract][Full Text] [Related]
45. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
46. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients.
Provinciali M; Di Stefano G; Stronati S; Fabris N
Cytokine; 1998 Feb; 10(2):132-9. PubMed ID: 9512903
[TBL] [Abstract][Full Text] [Related]
47. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).
Leung KN; Mak NK; Fung MC; Hapel AJ
Immunology; 1994 Jan; 81(1):65-72. PubMed ID: 8132222
[TBL] [Abstract][Full Text] [Related]
48. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
Ellis TM; McKenzie RS; Simms PE; Helfrich BA; Fisher RI
J Immunol; 1989 Dec; 143(12):4282-6. PubMed ID: 2512355
[TBL] [Abstract][Full Text] [Related]
49. Bioactive human recombinant tumor necrosis factor-alpha: an unstable dimer?
Petersen CM; Nykjaer A; Christiansen BS; Heickendorff L; Mogensen SC; Møller B
Eur J Immunol; 1989 Oct; 19(10):1887-94. PubMed ID: 2583226
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-6 is a mediator of TNF-alpha regulation of LAK cell function.
Iho S; Golub SH; Shau H
Scand J Immunol; 1993 Aug; 38(2):137-41. PubMed ID: 8346413
[TBL] [Abstract][Full Text] [Related]
51. 75- but not 55-kDa tumor necrosis factor receptor is active in the homotypic aggregation and proliferation of human lymphokine-activated T killer (T-LAK) cells in vitro.
Abe Y; Yamauchi K; Kimura S
J Leukoc Biol; 1995 Mar; 57(3):462-8. PubMed ID: 7884318
[TBL] [Abstract][Full Text] [Related]
52. The autocrine role of tumor necrosis factor in the proliferation and functional differentiation of human lymphokine-activated T killer cells (T-LAK) in vitro.
Innins EK; Gatanaga M; Van Eden M; Knudsen KL; Granger GA; Gatanaga T
Cytokine; 1992 Sep; 4(5):391-6. PubMed ID: 1421001
[TBL] [Abstract][Full Text] [Related]
53. Defect in generation of LAK cell activity under oxygen-limited conditions.
Ishizaka S; Kimoto M; Tsujii T
Immunol Lett; 1992 May; 32(3):209-14. PubMed ID: 1500092
[TBL] [Abstract][Full Text] [Related]
54. Augmentative effects of phytohemagglutinin-P on proliferation and cytotoxicity of interleukin-2-activated canine peripheral blood lymphocytes.
Mizuno S; Fujinaga T; Kurosawa T
Zentralbl Veterinarmed A; 1996 Jul; 43(5):289-96. PubMed ID: 8779803
[TBL] [Abstract][Full Text] [Related]
55. Tumor necrosis factor-alpha is chemokinetic for lymphokine-activated killer cells: regulation by cyclic adenosine monophosphate.
Maghazachi AA
J Leukoc Biol; 1991 Mar; 49(3):302-8. PubMed ID: 1847719
[TBL] [Abstract][Full Text] [Related]
56. Impaired Cytotoxic Activity of Interleukin 2 (IL 2)-cultured Large Granular Lymphocytes (LGL) in Childhood Acute Lymphoblastic Leukemia. Quantitative Measurement of IL 2 Receptor Expression of IL 2-cultured LGL.
Yamada S; Ichikawa M; Komiyama A
Leuk Lymphoma; 1991; 6(1):65-73. PubMed ID: 27457578
[TBL] [Abstract][Full Text] [Related]
57. [Involvement of tumor necrosis factor in the generation of LAK killer cells].
Chouaib S; Blay JY
Pathol Biol (Paris); 1990 Jan; 38(1):47-52. PubMed ID: 2308780
[TBL] [Abstract][Full Text] [Related]
58. Tumor necrosis factor alpha: a costimulator for cytotoxic cell differentiation.
Chouaib S
Nouv Rev Fr Hematol (1978); 1991; 33(6):471-5. PubMed ID: 1818300
[TBL] [Abstract][Full Text] [Related]
59. Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.
Blay JY; Branellec D; Robinet E; Dugas B; Gay F; Chouaïb S
J Clin Invest; 1990 Jun; 85(6):1909-13. PubMed ID: 2161432
[TBL] [Abstract][Full Text] [Related]
60. Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors.
Blay JY; Bertoglio J; Fradelizi D; Chouaib S
Int J Cancer; 1989 Oct; 44(4):598-604. PubMed ID: 2793231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
